Roux-en-Y gastric bypass surgery remains the most effective treatment for obesity as it induces greater, more sustained weight loss than other procedures with almost immediate, weight-independent effects on glycaemic control, insulin sensitivity and GLP-1 secretion (45, 69). This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.